A critical look: Challenges in differentiating human pluripotent stem cells into desired cell types and organoids

Citations Over TimeTop 13% of 2019 papers

Abstract

Too many choices can be problematic. This is certainly the case for human pluripotent stem cells (hPSCs): they harbor the potential to differentiate into hundreds of cell types; yet it is highly challenging to exclusively differentiate hPSCs into a single desired cell type. This review focuses on unresolved and fundamental questions regarding hPSC differentiation and critiquing the identity and purity of the resultant cell populations. These are timely issues in view of the fact that hPSC-derived cell populations have or are being transplanted into patients in over 30 ongoing clinical trials. While many in vitro differentiation protocols purport to "mimic development," the exact number and identity of intermediate steps that a pluripotent cell takes to differentiate into a given cell type in vivo remains largely unknown. Consequently, most differentiation efforts inevitably generate a heterogeneous cellular population, as revealed by single-cell RNA-sequencing and other analyses. The presence of unwanted cell types in differentiated hPSC populations does not portend well for transplantation therapies. This provides an impetus to precisely control differentiation to desired ends-for instance, by logically blocking the formation of unwanted cell types or by overexpressing lineage-specifying transcription factors-or by harnessing technologies to selectively purify desired cell types. Conversely, approaches to differentiate three-dimensional "organoids" from hPSCs intentionally generate heterogeneous cell populations. While this is intended to mimic the rich cellular diversity of developing tissues, whether all such organoids are spatially organized in a manner akin to native organs (and thus, whether they fully qualify as organoids) remains to be fully resolved. This article is categorized under: Adult Stem Cells > Tissue Renewal > Regeneration: Stem Cell Differentiation and Reversion Gene Expression > Transcriptional Hierarchies: Cellular Differentiation Early Embryonic Development: Gastrulation and Neurulation.

Related Papers

• → The reprogramming therapy for a patient with advanced hepatocellular carcinoma by using human-induced pluripotent stem (iPS) cells technology(2013)3 cited
• → Standard operating protocol of hepatic organoid differentiation from human induced pluripotent stem cells(2022)1 cited
• Abstract 20894: Therapeutic Efficacy of the Exosomes Derived From Human Induced Pluripotent Stem Cells (iPSCs) vs. Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes (iCMs) in Murine Myocardial Injury Model(2017)
• → Modeling Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells(2016)
• → Midbrain-like Organoids generation from hiPSCs v1(2022)